低剂量阿司匹林预防慢性高血压孕妇重叠子痫前期的系统评价与Meta分析
该系统评价与Meta分析纳入9项研究共2150例慢性高血压单胎孕妇,评估妊娠期低剂量阿司匹林能否降低重叠子痫前期及不良围产结局的比值。随机对照试验中重叠子痫前期比值未显著降低(OR 0.83,95%CI 0.55-1.25,低质量证据),观察性研究中亦无显著降低(OR 1.21,95%CI 0.78-1.87,极低质量证据);早产比值显著降低(OR 0.63,95%CI 0.45-0.89,中等质量证据)。
要点
- 随机对照试验中低剂量阿司匹林未显著降低重叠子痫前期比值(OR 0.83,95%CI 0.55-1.25,低质量证据)。
- 观察性研究中重叠子痫前期比值无显著降低(OR 1.21,95%CI 0.78-1.87,极低质量证据)。
- 早产比值显著降低(OR 0.63,95%CI 0.45-0.89,中等质量证据),作者认为支持继续使用阿司匹林预防。
核心结论
- 本Meta分析未能证明慢性高血压孕妇使用低剂量阿司匹林可显著改变重叠子痫前期、小于胎龄儿或围产期死亡的比值。
- 但早产比值显著降低,作者认为这支持继续使用阿司匹林预防。
研究设计与样本
- 系统评价与Meta分析,检索Embase、MEDLINE、Cochrane Central Register of Controlled Trials、ClinicalTrials.gov、世界卫生组织国际临床试验注册平台和EU Clinical Trials Register,检索时间为2021年9月,仅纳入人类研究,无时间或语言限制。
- 纳入报告慢性高血压单胎孕妇的队列、病例对照和随机对照研究,比较妊娠期低剂量阿司匹林使用与对照臂。
- 共纳入9项研究(3项回顾性队列研究和6项随机试验),包括2150例慢性高血压孕妇。
- 采用RoB 2和ROBINS-I工具评估偏倚风险,随机效应模型进行Meta分析,估计比值比及95%置信区间和预测区间,采用GRADE方法评估数据质量。
- 异质性探讨涉及研究方法学、阿司匹林开始时机和早产子痫前期结局。
主要发现
- 随机对照试验中低剂量阿司匹林未显著降低重叠子痫前期比值(OR 0.83,95%CI 0.55-1.25;预测区间0.27-2.56;低质量证据)。
- 观察性研究中重叠子痫前期比值无显著降低(OR 1.21,95%CI 0.78-1.87;预测区间0.07-20.80;极低质量证据)。
- 低剂量阿司匹林未降低早产子痫前期比值(OR 1.17,95%CI 0.74-1.86),早期开始阿司匹林无显著影响。
- 对小于胎龄儿或围产期死亡无显著影响;早产比值显著降低(OR 0.63,95%CI 0.45-0.89;中等质量证据)。
关键数值与推荐
- 重叠子痫前期:随机对照试验OR 0.83(95%CI 0.55-1.25;预测区间0.27-2.56;低质量证据),观察性研究OR 1.21(95%CI 0.78-1.87;预测区间0.07-20.80;极低质量证据)。
- 早产子痫前期:OR 1.17(95%CI 0.74-1.86)。
- 早产:OR 0.63(95%CI 0.45-0.89;中等质量证据)。
临床怎么用
- 作者认为早产比值显著降低支持继续使用阿司匹林预防。
局限性
- 证据质量受异质性和偏倚风险限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This systematic review and meta-analysis investigated whether the use of low-dose aspirin during pregnancy by women with chronic hypertension reduces the odds of superimposed preeclampsia and poor perinatal outcomes. DATA SOURCES: In September 2021, the following sources were searched: Embase, MEDLINE, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform, and EU Clinical Trials Register. Only human studies were included, with no time or language restrictions. STUDY ELIGIBILITY CRITERIA: Cohort, case-control, and randomized controlled studies reporting women with chronic hypertension pregnant with a singleton were included. Eligible studies compared low-dose aspirin use during pregnancy with a control arm. METHODS: Risk of bias was assessed using the RoB 2 and ROBINS-I tools. A meta-analysis was performed using a random-effects model, estimating odds ratios and 95% confidence and prediction intervals, and the quality of data was assessed with the GRADE approach. Heterogeneity was investigated in regard to study methodology, timing of commencement of aspirin, and the outcome of preterm preeclampsia. RESULTS: Nine studies (3 retrospective cohort studies and 6 randomized trials) including 2150 women with chronic hypertension were included. Low-dose aspirin prophylaxis did not significantly reduce the odds of superimposed preeclampsia in the randomized controlled trials (odds ratio, 0.83; 95% confidence interval, 0.55-1.25; prediction interval, 0.27-2.56; low-quality evidence) or observational studies (odds ratio, 1.21; 95% confidence interval, 0.78-1.87; prediction interval, 0.07-20.80; very low-quality evidence). Low-dose aspirin also did not reduce the odds of preterm preeclampsia (odds ratio, 1.17; 95% confidence interval, 0.74-1.86), and early aspirin initiation had no significant impact. There was no significant effect on small-for-gestational-age neonates or perinatal mortality; however, there was a significant reduction in preterm birth (odds ratio, 0.63; 95% confidence interval, 0.45-0.89; moderate-quality evidence). The quality of the evidence is limited by heterogeneity and risk of bias. CONCLUSION: This meta-analysis was unable to demonstrate a significant change in the odds of superimposed preeclampsia, small-for-gestational-age infants, or perinatal mortality with the use of low-dose aspirin in women with chronic hypertension. However, significant reduction in preterm birth justifies the continued use of aspirin prophylaxis. This work was prospectively registered on the International Prospective Register of Systematic Reviews (registration number CRD42021285921).
引用
- Richards EMF, Giorgione V, Stevens O, et al. Low-dose aspirin for the prevention of superimposed preeclampsia in women with chronic hypertension: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022. PMID: 36209937. doi:10.1016/j.ajog.2022.09.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。